These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 10063990

  • 1. The factor V gene A4070G mutation and the risk of venous thrombosis.
    Alhenc-Gelas M, Nicaud V, Gandrille S, van Dreden P, Amiral J, Aubry ML, Fiessinger JN, Emmerich J, Aiach M.
    Thromb Haemost; 1999 Feb; 81(2):193-7. PubMed ID: 10063990
    [Abstract] [Full Text] [Related]

  • 2. Probability of recurrence of thrombosis in patients with and without factor V Leiden.
    Rintelen C, Pabinger I, Knöbl P, Lechner K, Mannhalter C.
    Thromb Haemost; 1996 Feb; 75(2):229-32. PubMed ID: 8815565
    [Abstract] [Full Text] [Related]

  • 3. Venous thromboembolic disease and the prothrombin, methylene tetrahydrofolate reductase and factor V genes.
    Alhenc-Gelas M, Arnaud E, Nicaud V, Aubry ML, Fiessinger JN, Aiach M, Emmerich J.
    Thromb Haemost; 1999 Apr; 81(4):506-10. PubMed ID: 10235429
    [Abstract] [Full Text] [Related]

  • 4. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC, Guasch JF, Kamphuisen PW, Vos HL, Rosendaal FR, Bertina RM.
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [Abstract] [Full Text] [Related]

  • 5. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M, Gisslinger H, Tosetto A, Rintelen C, Mannhalter C, Pabinger I, Heis N, Castaman G, Missiaglia E, Lechner K, Rodeghiero F.
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [Abstract] [Full Text] [Related]

  • 6. [Activated protein C resistance and venous thrombophilia: molecular genetic prevalence study in the German population].
    Ehrenforth S, Klinke S, von Depka Prondzinski M, Kreuz W, Ganser A, Scharrer I.
    Dtsch Med Wochenschr; 1999 Jun 25; 124(25-26):783-7. PubMed ID: 10414227
    [Abstract] [Full Text] [Related]

  • 7. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.
    Thromb Haemost; 2001 Sep 25; 86(3):809-16. PubMed ID: 11583312
    [Abstract] [Full Text] [Related]

  • 8. The factor V R2 allele: risk of venous thromboembolism, factor V levels and resistance to activated protein C.
    Luddington R, Jackson A, Pannerselvam S, Brown K, Baglin T.
    Thromb Haemost; 2000 Feb 25; 83(2):204-8. PubMed ID: 10739373
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Molecular characterization of a type I quantitative factor V deficiency in a thrombosis patient that is "pseudo homozygous" for activated protein C resistance.
    Guasch JF, Lensen RP, Bertina RM.
    Thromb Haemost; 1997 Feb 25; 77(2):252-7. PubMed ID: 9157576
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Factor V gene A4070G mutation and the risk of cerebral veno-sinus thrombosis occurring during puerperium.
    Dindagur N, Kruthika-Vinod TP, Christopher R.
    Thromb Res; 2007 Feb 25; 119(4):497-500. PubMed ID: 16781765
    [Abstract] [Full Text] [Related]

  • 13. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.
    Haematologica; 2000 Dec 25; 85(12):1271-6. PubMed ID: 11114134
    [Abstract] [Full Text] [Related]

  • 14. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
    Kostka H, Schwarz T, Schellong S, Mix C, Kuhlisch E, Temelkova-Kurktschiev T, Henkel E, Köhler C, Gehrisch S, Siegert G.
    Blood Coagul Fibrinolysis; 2003 Jan 25; 14(1):49-56. PubMed ID: 12544728
    [Abstract] [Full Text] [Related]

  • 15. New molecular insights into the genetics of thrombophilia. Resistance to activated protein C caused by Arg506 to Gln mutation in factor V as a pathogenic risk factor for venous thrombosis.
    Dahlbäck B.
    Thromb Haemost; 1995 Jul 25; 74(1):139-48. PubMed ID: 8578447
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L, Nguyen P, Hezard N, Musharrafieh U, Almawi WY, Mahjoub T.
    Exp Mol Pathol; 2007 Dec 25; 83(3):480-3. PubMed ID: 17555744
    [Abstract] [Full Text] [Related]

  • 18. Factor V Leiden: an additional risk factor for thrombosis in protein S deficient families?
    Koeleman BP, van Rumpt D, Hamulyák K, Reitsma PH, Bertina RM.
    Thromb Haemost; 1995 Aug 25; 74(2):580-3. PubMed ID: 8584987
    [Abstract] [Full Text] [Related]

  • 19. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
    Martinelli I, Legnani C, Bucciarelli P, Grandone E, De Stefano V, Mannucci PM.
    Thromb Haemost; 2001 Sep 25; 86(3):800-3. PubMed ID: 11583310
    [Abstract] [Full Text] [Related]

  • 20. Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
    Castaman G, Tosetto A, Simioni M, Ruggeri M, Madeo D, Rodeghiero F.
    Thromb Haemost; 2001 Sep 25; 86(3):804-8. PubMed ID: 11583311
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.